Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA.
Chemical reduction of the highly active quinone-containing antitumor drugs, adriamycin and daunorubicin formed the same partially reduced free radical previously reported [9] by microsomal activation. In vitro incubation of the chemically activated free radical intermediates with DNA resulted in covalent binding of these drugs to DNA. The adriamycin semiquinone radical has a greater affinity for DNA and covalent complexes up to one adriamycin per 12 nucleotides were obtained. The daunorubicin semiquinone radical, on the other hand, showed a lesser binding affinity and gave rise to complexes in which one drug molecule was covalently bound per 135 nucleotides. The stronger covalent binding of adriamycin to DNA may account for more severe DNA damage induced by this drug.
D016227:Benzoquinones; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA; D003630:Daunorubicin; D004317:Doxorubicin; D005609:Free Radicals; D008937:Mitomycins; D011809:Quinones
D016227:Benzoquinones; D005609:Free Radicals; D008937:Mitomycins; D011809:Quinones; C025232:semiquinone radicals; D004317:Doxorubicin; D004247:DNA; D003630:Daunorubicin